ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01065623
Recruitment Status : Terminated (The study was terminated due to safety reasons)
First Posted : February 9, 2010
Last Update Posted : October 1, 2014
Sponsor:
Information provided by (Responsible Party):
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2010
  Actual Study Completion Date : August 2010